AN ACT RELATING TO BUSINESSES AND PROFESSIONS -- THE PRESCRIPTION DRUG SALES REPRESENTATIVE DISCLOSURE ACT
Summary
Requires prescription drug manufacturers to file a detailed, updated list of each pharmaceutical sales representative engaged by the manufacturer and to pay an annual fee for each name on list.
Bill status
passed
3 of 5 stages cleared
Introduction
Jan 2024
Committee Review
Jun 2024
House Passage
Jun 2024
Senate Passage
Governor
Introduced Jan 5, 2024
Last action Jun 13, 2024
Floor votes · House Jun 13, 2024
How they voted
69–4
Passed · 1 other
Total votes 74
Jun 13, 2024
D
Democratic64
96% Yea
I
Independent1
100% Yea
R
Republican9
66% Yea
Vote distribution
All Yea
All Nay
Mixed
No data
Full legislative history
Actions timeline
Total actions
9
Key actions
3
Committee
3
Jun 13, 2024
Lower · Passed
06/13/2024 House passed as amended (floor amendment)
lower
Jun 12, 2024
Legislature · Passed
06/12/2024 Committee recommends passage
legislature
Feb 29, 2024
Committee
02/29/2024 Committee recommended measure be held for further study
legislature
Jan 29, 2024
Legislature · Passed
01/29/2024 Committee postponed at request of sponsor (01/30/2024)
legislature
Jan 5, 2024
Introduced
01/05/2024 Introduced, referred to House Health & Human Services
lower
7 primary · 0 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about HB 7041
Scope: RI
Hi! I can help you understand HB 7041. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline